Ortec gets US nod to start diabetic foot ulcer trial
This article was originally published in Clinica
Executive Summary
Tissue engineering firm Ortec International has received clearance from the FDA to begin a pivotal trial of its OrCel technology for treating diabetic foot ulcers (DFU).